Skip to main content

Table 4 Antimicrobial Resistance Rates in all Hospitals

From: The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals

Multidrug-resistant organism

Number of patients treated for MDRO

Prevalence of MDRO (%, number of patients treated for MDRO on number of patients receiving antimicrobials for therapeutic use (CAI and HAI))

MRSA

29

2.7

MRCoNS

6

0.6

VRE

10

0.9

ESBL

20

1.8

3-ceph

11

1.0

CRE

0

 

ESBL-NF

2

0.2

CR-NF

2

0.2

Other MDRO

19

1.7

  1. Abbreviations: 3-ceph 3rd generation cephalosporin resistant Enterobacteriaceae (non-ESBL or ESBL status unknown), CAI community-acquired infection, CRE carbapenem-resistant Enterobacteriaceae, CR-NF carbapenem-resistant non-fermenter Gram-negative bacilli, ESBL bacteria producing extended-spectrum beta-lactamases, ESBL-NF ESBL-producing non-fermenter Gram-negative bacilli, HAI healthcare-associated infection, MDRO multi-drug resistant organism, MRCoNS methicillin-resistant coagulase negative staphylococci, MRSA methicillin-resistant Staphylococcus aureus, VRE Vancomycin-resistant enterococci
Back to article page

Antimicrobial Resistance & Infection Control

ISSN: 2047-2994

Contact us